Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
MRI in multiple sclerosis: a review of the current literature.
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
The benefits of exercise training in multiple sclerosis.
Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature.
The microglial sensome revealed by direct RNA sequencing.
A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
Drug record: Amiloride
Naltrexone
Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
Pages
« first
‹ previous
…
165
166
167
168
169
170
171
172
173
…
next ›
last »